Today: 8 février 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-matrice-30t-pl- Page 175

Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg Commerce (NEGG) Stock Rockets on AI & “Meme” Hype — 688% YTD Gains, CEO Upgraded to Board

Newegg shares jumped 40.8% to close at $66.72 on Oct 24, following a 7% gain the previous day and heavy trading volume. The stock is up roughly 500–600% over the past year, despite sharp volatility. In August, Newegg reported H1 2025 sales of $695.7 million, up 12.6% year-over-year, and turned profitable on an adjusted EBITDA basis. CEO Anthony Chow cited new GPU/CPU launches as key growth drivers.
25 octobre 2025
·
Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Hidden ‘Planet-Killer’ Asteroid Found in Sun’s Glare Exposes Dangerous Blind Spot

Astronomers have discovered asteroid 2025 SC79, a 700-meter-wide object orbiting the sun every 128 days—second-fastest known—inside Venus’s orbit. The asteroid, hidden by the sun’s glare until twilight observations, poses no immediate threat to Earth, according to orbital data. Scientists warn similar objects are hard to detect. NASA plans to launch the NEO Surveyor telescope by 2027 to improve detection.
26 octobre 2025
22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group (XXII) Soars After $9.5M Windfall, Expands Low-Nicotine Cigarette Rollout

22nd Century Group shares surged over 39% in after-hours trading to about $2.10 after securing a $9.5 million insurance settlement. The company, now debt-free, recently expanded its FDA-authorized VLN low-nicotine cigarettes into 140 Circle K stores in Illinois and has sales authorized in 45 states. Despite these moves, 22nd Century remains unprofitable and will report Q3 results on November 4.
29 octobre 2025
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb reported Q3 adjusted EPS of $1.63 on $12.2 billion revenue, beating estimates, and raised its 2025 outlook. Shares rebounded 3–4% after hitting a 52-week low, with dividend yield now near 5.5%. New drugs like Opdivo and Eliquis outperformed, offsetting a sharp Revlimid decline. The company acquired Orbital Therapeutics and launched schizophrenia drug Cobenfy, posting $62 million in early sales.
30 octobre 2025
··
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs shares surged over 12% to $191 intraday on Oct. 31, 2025, though still below their September high of $262.90. The stock rebounded after a volatile month that included a 19% drop on Oct. 15 and the Oct. 22 acquisition of aiXscale Photonics. Q2 revenue jumped 150% year-over-year to $191.9 million, beating estimates. Institutional investors hold about 60% of shares, while insiders sold over $190 million in August.
31 octobre 2025
··
Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

Virgin Galactic’s Wild 2025 Ride: Space Tourism Liftoff, Stock Surges & Cash Burn – What’s Next for SPCE?

Virgin Galactic shares surged over 40% in October 2025 before dropping back, closing at $3.94 on Oct. 31, down about 40% year-to-date and 99% below their 2021 peak. The company paused commercial flights after June 2024 and is burning $100–125 million per quarter, with about 18 months of cash left. Wall Street targets hover near $4, with some analysts warning of further downside.
1 novembre 2025
··
Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Hims & Hers said Oct. 29 it will offer clinician-supervised GLP-1 “microdose” plans using compounded semaglutide for metabolic health, priced at $1,200 for six months. The drugs, not FDA-approved, target patients with conditions like sleep apnea or high blood pressure. Medical experts warn safety data is limited and compounded versions carry risks. HIMS stock rose 2–3% after the announcement.
3 novembre 2025
···
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

From Bitcoin Miner to AI Cloud Powerhouse: Iris Energy’s Meteoric Rise (IREN Stock Soars on $9.7B Microsoft Deal)

Iris Energy (IREN) closed at $67.75 on Nov. 3, 2025, after announcing a $9.7 billion, five-year AI cloud contract with Microsoft, sending shares up 11.5%. The company’s market cap now tops $16.5 billion, up from $1 billion at the start of 2025. IREN posted FY2025 revenue of $501 million and net income of $86.9 million, driven by its pivot to AI cloud services and continued Bitcoin mining.
4 novembre 2025
···
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 novembre 2025
··
Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture (SCNX) shares surged 40% to $0.99 pre-market Nov. 4 after its hypertension drug Arbli™ was added to major insurance formularies, expanding coverage to over 100 million people. The company reported just $0.13 million in revenue and a $20 million net loss over the past year. SCNX trades near $0.71, down from a 52-week high of $8.81. Analysts remain cautious, citing high cash burn and uncertain Arbli sales.
4 novembre 2025
·
Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork reported Q3 2025 revenue of $201.7 million, beating estimates, and raised its full-year outlook above consensus. Shares surged nearly 20% to around $17 after the results. Wall Street analysts boosted price targets, with Goldman Sachs setting a $25 target citing AI-driven growth. AI-related freelance work on the platform jumped 53% year-over-year.
4 novembre 2025
···
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Soars to Record High After Huge Q4 Earnings Beat – What’s Next for AAPL in 2025?

Apple traded near $269 on Nov. 4, 2025, close to its 52-week high of $277.32, with shares up 26% since August and market cap at $3.95 trillion. The company reported record Q4 revenue of $102.5 billion, up 8% year-over-year, and forecast double-digit iPhone sales growth for the holiday quarter. Analyst targets are split, with consensus near $285. Technical resistance is seen at $275–$280.
4 novembre 2025
···
Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise Holdings (NASDAQ: ORIS) closed at $0.19 on Nov 4, 2025, down 95% from its IPO, after a year of extreme volatility and a July share offering that triggered a 66% one-day crash. The China-based tea company reported 2024 revenue of $15 million (–38% YoY) and net income of $2.09 million (–82%), despite holding $43 million in cash and no debt. ORIS risks Nasdaq delisting unless it regains compliance by Dec 29.
4 novembre 2025
·
Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks shares surged nearly 40% year-to-date in 2025, far outpacing the S&P 500. The stock hit a record high in late October before dropping about 12% after Q3 earnings, as guidance signaled flat Q4 revenue and lower margins. Q3 revenue rose 27.5% to $2.31 billion, beating estimates. Most analysts remain positive, but some cite high valuation and slowing growth.
5 novembre 2025
·
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Technologies’ shares have surged over 150% in 2025, hitting an all-time high near $207 before a post-earnings dip to the upper-$180s. Q3 revenue soared 63% to $1.18 billion, with U.S. commercial sales more than doubling. The company posted $0.18 GAAP EPS and $540 million in free cash flow. Michael Burry disclosed a large bearish bet, while Jim Cramer raised his price target to $200.
5 novembre 2025
···
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 novembre 2025
···
Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung will debut 10.7Gbps LPDDR6 DRAM and a compact Gen5 PM9E1 SSD with up to 14.8GB/s read and 13.4GB/s write speeds at CES 2026 in Las Vegas. The 12nm LPDDR6 offers about 21% better energy efficiency over previous models. The PM9E1 SSD features a 42mm M.2 form factor, “Presto” controller, V8 TLC V-NAND, and up to 4TB capacity. Both products are CES Innovation Awards honorees.
8 novembre 2025
··
1 … 173 174 175 176

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Aucun chèque de relance de 2 000 $ de l’IRS n’arrivera en février 2026 — mais les propos de Trump sur les « chèques de tarifs » entretiennent les rumeurs

7 février 2026
Aucun nouveau chèque de relance fédéral n’est prévu pour février 2026, l’IRS n’a fait aucune annonce et le Congrès n’a rien approuvé. Donald Trump a évoqué à NBC la possibilité de chèques de droits de douane de 2 000 $, sans engagement ni calendrier précis. L’IRS met en garde contre les arnaques promettant des paiements.
Go toTop